BioTech/Drugs - Beverly, Massachusetts, US
LexaGene Life Sciences is an early-stage company developing a novel automated PCR-based bioburden testing system. The technology will be a significant improvement in the key needs of speed, ease-of-use, and sensitivity for >95% of microbial contaminants. Our initial target market is the biopharmaceutical manufacturing industry.
Outlook
Hubspot
Sendgrid
Microsoft Office 365
Google Cloud Hosting